Long-term mechanical circulatory support (LT-MCS) is an important treatment modality for
patients with severe heart failure. Different devices are available, and many—sometimes …

The field of mechanical circulatory support has made great strides in the preceding 2
decades. Although pediatric mechanical circulatory support has lagged behind that of …

Mechanical circulatory support has seen numerous advances in the recent years, with
important observations made to guide patient selection for the therapy, indications for use …

Background Continuous-flow (CF) ventricular assist devices (VADs) have largely replaced
pulsatile-flow VADs in adult patients. However, there are few data on CF VADs among …

Background Ventricular assist devices (VADs) have been used in children on an increasing
basis in recent years. One-year survival rates are now> 80% in multiple reports. In this report …

1. Background More than 20 years have passed since heart transplantation began to be
performed under the Organ Transplant Law enacted in 1997. The Law was amended to …

Continuous-flow ventricular assist devices (CF-VADs), designed for patients with a body
surface area (BSA) Z1. 2 m2, have improved survival free from stroke and device failure in …

The primary objectives of this study were to describe the characteristics and survival
outcomes for children supported with the HeartWare HVAD® system from the global …

The domain of pediatric ventricular assist device (VAD) has recently gained considerable
attention. Despite the fact that, historically, the practice of pediatric mechanical circulatory …

Background Cardiac disease is a leading cause of stroke in children, yet limited data
support the current stroke prevention and treatment recommendations. A multidisciplinary …